Stroke prevention with the PCSK9 (proprotein convertase subtilisin-kexin type 9) inhibitor evolocumab added to statin in high-risk patients with stable atherosclerosis - MD Linx
[unable to retrieve full-text content] NAVIGATING THE SILENCE: RECONSIDERING TREATMENT PARADIGMS IN ASYMPTOMATIC SEVERE AORTIC STENOSIS ScienceDirect.com
Comments
Post a Comment